New drug combo aims to control resistant blood cancers
Disease control
Recruiting now
This study is testing whether combining two oral medications, pirtobrutinib and venetoclax, can control chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in patients whose cancer has continued to grow despite treatment with standard BTK inhibitor drugs. The m…
Phase: PHASE2 • Sponsor: Kerry Rogers • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC